HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ari Elson Selected Research

Class 4 Receptor-Like Protein Tyrosine Phosphatases

1/2019Protein tyrosine phosphatase alpha inhibits hypothalamic leptin receptor signaling and regulates body weight in vivo.
1/2012Epidermal growth factor receptor (EGFR)-mediated positive feedback of protein-tyrosine phosphatase epsilon (PTPepsilon) on ERK1/2 and AKT protein pathways is required for survival of human breast cancer cells.
5/2011Protein tyrosine phosphatase epsilon affects body weight by downregulating leptin signaling in a phosphorylation-dependent manner.
6/2008Protein tyrosine phosphatase epsilon and Neu-induced mammary tumorigenesis.
2/2008Protein-tyrosine phosphatase epsilon regulates Shc signaling in a kinase-specific manner: increasing coherence in tyrosine phosphatase signaling.
3/2004Protein tyrosine phosphatase epsilon activates Yes and Fyn in Neu-induced mammary tumor cells.
5/2003Protein tyrosine phosphatase epsilon inhibits signaling by mitogen-activated protein kinases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ari Elson Research Topics

Disease

9Neoplasms (Cancer)
06/2019 - 05/2003
6Breast Neoplasms (Breast Cancer)
06/2019 - 01/2012
3Osteopetrosis
01/2021 - 01/2020
2Inborn Genetic Diseases (Disease, Hereditary)
01/2020 - 01/2013
2Obesity
01/2019 - 05/2011
2Bone Resorption
01/2019 - 09/2008
2Body Weight (Weight, Body)
01/2019 - 05/2011
2Carcinogenesis
01/2018 - 06/2008
1Bone Diseases (Bone Disease)
01/2019
1Arthritis (Polyarthritis)
02/2016
1Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2014
1Weight Gain
05/2011
1Hypersensitivity (Allergy)
05/2011
1Hyperplasia
06/2008

Drug/Important Bio-Agent (IBA)

7Class 4 Receptor-Like Protein Tyrosine PhosphatasesIBA
01/2019 - 05/2003
7Tyrosine (L-Tyrosine)FDA Link
01/2018 - 05/2003
6Protein Tyrosine PhosphatasesIBA
01/2019 - 05/2003
5Proteins (Proteins, Gene)FDA Link
06/2019 - 06/2008
4Pharmaceutical PreparationsIBA
06/2019 - 01/2018
4Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2019 - 06/2008
46-pyruvoyltetrahydropterin synthase (PTPS)IBA
01/2019 - 01/2013
4Phosphoric Monoester Hydrolases (Phosphatases)IBA
05/2011 - 05/2003
4Phosphotransferases (Kinase)IBA
06/2008 - 05/2003
3Sorting NexinsIBA
01/2021 - 01/2020
3Trastuzumab (Herceptin)FDA Link
06/2019 - 11/2018
2Dual-Specificity PhosphatasesIBA
06/2019 - 11/2018
2LeptinIBA
05/2014 - 05/2011
1Protons (Proton)IBA
01/2020
1human ERBB2 proteinIBA
06/2019
1Epidermal Growth Factor (EGF)IBA
01/2019
1Leptin ReceptorsIBA
01/2019
1Insulin (Novolin)FDA Link
05/2014
1Biomarkers (Surrogate Marker)IBA
10/2012
1ErbB Receptors (EGF Receptor)IBA
01/2012
1src-Family KinasesIBA
06/2008

Therapy/Procedure

2Therapeutics
01/2018 - 12/2013
1Ovariectomy (Oophorectomy)
05/2011